Correlation Between Alterola Biotech and HLS Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Alterola Biotech and HLS Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alterola Biotech and HLS Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alterola Biotech and HLS Therapeutics, you can compare the effects of market volatilities on Alterola Biotech and HLS Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alterola Biotech with a short position of HLS Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alterola Biotech and HLS Therapeutics.

Diversification Opportunities for Alterola Biotech and HLS Therapeutics

-0.59
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Alterola and HLS is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding Alterola Biotech and HLS Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on HLS Therapeutics and Alterola Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alterola Biotech are associated (or correlated) with HLS Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of HLS Therapeutics has no effect on the direction of Alterola Biotech i.e., Alterola Biotech and HLS Therapeutics go up and down completely randomly.

Pair Corralation between Alterola Biotech and HLS Therapeutics

Given the investment horizon of 90 days Alterola Biotech is expected to generate 6.99 times more return on investment than HLS Therapeutics. However, Alterola Biotech is 6.99 times more volatile than HLS Therapeutics. It trades about 0.06 of its potential returns per unit of risk. HLS Therapeutics is currently generating about -0.02 per unit of risk. If you would invest  5.50  in Alterola Biotech on November 2, 2024 and sell it today you would lose (5.14) from holding Alterola Biotech or give up 93.45% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Alterola Biotech  vs.  HLS Therapeutics

 Performance 
       Timeline  
Alterola Biotech 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Alterola Biotech are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak basic indicators, Alterola Biotech demonstrated solid returns over the last few months and may actually be approaching a breakup point.
HLS Therapeutics 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in HLS Therapeutics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, HLS Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

Alterola Biotech and HLS Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Alterola Biotech and HLS Therapeutics

The main advantage of trading using opposite Alterola Biotech and HLS Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alterola Biotech position performs unexpectedly, HLS Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HLS Therapeutics will offset losses from the drop in HLS Therapeutics' long position.
The idea behind Alterola Biotech and HLS Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Complementary Tools

Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA